Your browser doesn't support javascript.
Enhanced Framework for COVID-19 Prediction with Computed Tomography Scan Images using Dense Convolutional Neural Network and Novel Loss Function.
Motwani, Anand; Shukla, Piyush Kumar; Pawar, Mahesh; Kumar, Manoj; Ghosh, Uttam; Numay, Waleed Al; Nayak, Soumya Ranjan.
  • Motwani A; Faculty, School of Computing Science & Engineering, VIT Bhopal University, Sehore (MP), 466114, India.
  • Shukla PK; Department of Computer Science & Engineering, University Institute of Technology, RGPV, Bhopal (MP), 462033, India.
  • Pawar M; Department of Information Technology, University Institute of Technology, RGPV, Bhopal (MP), 462033, India.
  • Kumar M; School of Computer Science, University of Petroleum and Energy Studies, Dehradun, India.
  • Ghosh U; Department of Computer Science & Data Science Meharry School of Computational Sciences Nashville, TN, USA.
  • Numay WA; King Saud University, Riyadh, SA.
  • Nayak SR; Amity School of Engineering and Technology, Amity University Uttar Pradesh, Noida, India.
Comput Electr Eng ; : 108479, 2022 Nov 14.
Article in English | MEDLINE | ID: covidwho-2243512
ABSTRACT
Recent studies have shown that computed tomography (CT) scan images can characterize COVID-19 disease in patients. Several deep learning (DL) methods have been proposed for diagnosis in the literature, including convolutional neural networks (CNN). But, with inefficient patient classification models, the number of 'False Negatives' can put lives at risk. The primary objective is to improve the model so that it does not reveal 'Covid' as 'Non-Covid'. This study uses Dense-CNN to categorize patients efficiently. A novel loss function based on cross-entropy has also been used to improve the CNN algorithm's convergence. The proposed model is built and tested on a recently published large dataset. Extensive study and comparison with well-known models reveal the effectiveness of the proposed method over known methods. The proposed model achieved a prediction accuracy of 93.78%, while false-negative is only 6.5%. This approach's significant advantage is accelerating the diagnosis and treatment of COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Randomized controlled trials Language: English Journal: Comput Electr Eng Year: 2022 Document Type: Article Affiliation country: J.compeleceng.2022.108479

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Randomized controlled trials Language: English Journal: Comput Electr Eng Year: 2022 Document Type: Article Affiliation country: J.compeleceng.2022.108479